ORIGINAL RESEARCH
Published on 18 Nov 2021
The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
doi 10.3389/fimmu.2021.748103
- 8,264 views
- 25 citations
15k
Total Downloads
62k
Total Views and Downloads
You will be redirected to our submission process.
ORIGINAL RESEARCH
Published on 18 Nov 2021
REVIEW
Published on 01 Nov 2021
REVIEW
Published on 01 Oct 2021
ORIGINAL RESEARCH
Published on 24 Aug 2021
REVIEW
Published on 30 Jun 2021
MINI REVIEW
Published on 28 May 2021
Frontiers in Public Health
Vaccines and Molecular TherapeuticsOffline